Didanosine
Indications
Registered South African indications:
- HIV infection
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Children < 6 years (cap)
- Coadministration with stavudine
Cautions
- Breastfeeding
- Renal impairment
- Hepatic impairment
- History of pancreatitis
- Patients at risk of lactic acidosis
- Chronic hepatitis B or C
- Sodium restricted diet
Adult dosage
Forms avail. in SA and covered in this monograph: tab, cap
HIV infection (additional agents required)
- Advanced disease
< 60kg
- Oral (tab): 125mg, 12hrly
- Oral (cap): 250mg, dly
> 60kg
- Oral (tab): 200mg, 12hrly
- Oral (cap): 400mg, dly
Dissolve the tablet in a glass of water
Cap: Do not cut/crush/chew/dissolve
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: tab
HIV infection (additional agents required)
- Advanced disease
Children younger than 6 months
- Not established for use
Older than 6 months
- Oral (tab): 200mg/m2/day, in 2 divided doses
| Body surface area (m2) | Dose |
| 1.1-1.4 | 100mg, 12hrly |
| 0.8-1.0 | 75mg, 12hrly |
| 0.5-0.7 | 50mg, 12hrly |
| > 0.4 | 25mg, 12hrly |
Dissolve the tablet in a glass of water
Special populations
Consult HIV/infectious disease specialists prior to any decisions related to ARV regimen termination/switch
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Central Nervous System Disorders
- Peripheral neurological symptoms
- Headache
- Fatigue
Gastrointestinal Disorders
- Diarrhoea
- Nausea and vomiting
- Abdominal pain
- Flatulence
- Dry mouth
- Parotid gland enlargement
Hepatobiliary Disorders
- Hepatitis
- Hepatic steatosis
- Hepatic failure
- Non-cirrhotic portal hypertension
- Abnormal alkaline phosphatase
Genitourinary Disorders
- Gynaecomastia
- Abnormal creatine phosphokinase
Endocrine and Metabolic Disorders
- Anorexia
Musculoskeletal Disorders
- Myalgia
- Arthralgia
- Rhabdomyolysis
- Myopathy
Skin and Subcutaneous Tissue Disorders
- Rash
- Alopecia
Immune, Blood and Lymphatic System Disorders
- Sialoadenitis
- Anemia
- Leukopenia
- Thrombocytopenia
- Anaphylactic reaction
- Fever
- Abnormal serum amylase
Sensory Disorders
- Dry eyes
- Retinal depigmentation
- Optic neuritis
Interactions
- Tenofovir
- Ganciclovir
- Valganciclovir
- Allopurinol
- Stavudine
- Hydroxyurea
- Ribavirin
- Lamivudine
- Methadone
Monitoring
- Serum potassium
- Uric acid
- Full blood count with differential
- CD4 count
- Viral load
- Amylase
- Ophthalmic examination
- Renal function
- Hepatic function
Mechanism of action
Didanosine is a purine nucleoside analog active against HIV-1 and HIV-2 in vitro. Following intracellular diffusion, didanosine is metabolised initially by 5’-nucleotidase and further by other cellular enzymes to its active derivative, 2’, 3’-dideoxyadenosine triphosphate (ddATP). DdATP functions as a competitive inhibitor of viral reverse transcriptase with respect to deoxyadenosine triphosphate and as a chain terminator of viral DNA synthesis.
Dosage forms
- Capsule
- Tablet
- Powder, oral
Formulation
Tablet 25mg
- Aspen Didanosine (Pharmacare)
- Sonke Didanosine (Ranbaxy)
Tablet 50mg
- Aspen Didanosine (Pharmacare)
- Sonke Didanosine (Ranbaxy)
Tablet 100mg
- Aspen Didanosine (Pharmacare)
- Sonke Didanosine (Ranbaxy)
Tablet 150mg
- Aspen Didanosine (Pharmacare)
Capsule 250mg
- Deladex (Novagen)
- Sonke Didanosine (Ranbaxy)
- Videx EC (Bristol Myers Squibb) originator
Capsule 400mg
- Deladex (Novagen)
- Sonke Didanosine (Ranbaxy)
- Videx EC (Bristol Myers Squibb) originator
References
1. SAMF 12th edition page 338 2. https://www.medicines.org.uk/emc/medicine/3596 250mg and 400mg capsule 3. https://drive.google.com/drive/folders/0B27NqM_vidrmTnBvTEpXTGlKT1U (01/2007_Bristol_Videx EC_caps) 4. https://drive.google.com/drive/folders/0B27NqM_vidrmTnBvTEpXTGlKT1U (19/09/2003_Pharmacare_Aspen Didanosine_tab) 5. https://www.uptodate.com/contents/didanosine-drug-information?source=search_result&search=Didanosine&selectedTitle=1~96 6. https://www.drugs.com/pregnancy/didanosine.html
Brands & products
17 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldtabletGeneric· 10 products
from R3.80/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Videx | 50 mg | 60 | S4 | R228.02 | R3.80 | R87.94 | 852961006 |
| Videx | 25 mg | 60 | S4 | R228.02 | R3.80 | R87.94 | 793221005 |
| Videx | 100 mg | 60 | S4 | R239.59 | R3.99 | R91.12 | 793213002 |
| Videx | 150 mg | 60 | S4 | R318.48 | R5.31 | R112.82 | 793205018 |
| Sonke-Didanosine 50 | 50 mg | 60 | S4 | R330.84 | R5.51 | R116.22 | 709871001 |
| Sonke-didanosine | 25 mg | 60 | S4 | R335.91 | R5.60 | R117.62 | 709870001 |
| Aspen Didanosine | 50 mg | 60 | S4 | R357.09 | R5.95 | R123.44 | 703332001 |
| Aspen Didanosine | 25 mg | 60 | S4 | R360.92 | R6.02 | R124.50 | 703330001 |
| Aspen Didanosine | 100 mg | 60 | S4 | R377.67 | R6.29 | R129.11 | 703333001 |
| Aspen Didanosine | 150 mg | 60 | S4 | R507.06 | R8.45 | R159.06 | 703392001 |
capsuleGeneric· 6 products
from R10.76/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Sonke-Didanosine 400 | 400 mg | 30 | S4 | R322.65 | R10.76 | R113.97 | 715671001 |
| Videx Ec 250 Mg | 250 mg | 30 | S4 | R325.56 | R10.85 | R114.77 | 704783001 |
| Deladex 250 Mg Capsules | 250 mg | 30 | S4 | R372.74 | R12.42 | R127.75 | 715073001 |
| Videx Ec 400Mg | 400 mg | 30 | S4 | R410.03 | R13.67 | R138.01 | 704785001 |
| Sonke Didanosine 250 | 250 mg | 30 | S4 | R450.60 | R15.02 | R149.17 | 715670001 |
| Deladex 400 Mg Capsules | 400 mg | 30 | S4 | R469.81 | R15.66 | R153.58 | 715074001 |
powderGeneric· 1 product
from R225.60/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Videx Paed | 2 g | 1 | S4 | R225.60 | R225.60 | R87.27 | 847518019 |
- Didanosine (syn. DDI
- ddI)Aspen Didanosine
- Deladex
- Sonke Didanosine
- Videx EC
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.